| Miss Amelia Tollefson, APNP | |
|
1130 W Sunset Dr, Waukesha, WI 53189-8422 | |
| (866) 389-2727 | |
| Not Available |
| Full Name | Miss Amelia Tollefson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1130 W Sunset Dr, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023366358 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 4946-33 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Amelia Tollefson, APNP 1130 W Sunset Dr, Waukesha, WI 53189-8422 Ph: (866) 389-2727 | Miss Amelia Tollefson, APNP 1130 W Sunset Dr, Waukesha, WI 53189-8422 Ph: (866) 389-2727 |
News Archive
Vascular Solutions, Inc. today announced that it has acquired the assets related to the EXPRO Elite™ and MICRO Elite™ snare products from Radius Medical Technologies, Inc. and its subsidiary, Radius Medical, LLC. Vascular Solutions has been selling the EXPRO Elite™ and MICRO Elite™ snares in the U.S. under a distribution relationship with Radius since 2008, while in international markets Radius has been selling the products through a network of independent distributors.
Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.
Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association's Scientific Sessions 2013 in Dallas and simultaneously published in the Journal of the American Medical Association. Previous smaller studies showed that low-dose dopamine or low-dose nesiritide could improve kidney function and reduce fluid overload that is often present in hospitalized acute heart failure patients by increasing urine production.
› Verified 2 days ago
Mr. Carla L Foley, MSN FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20611 Watertown Rd, Waukesha, WI 53186 Phone: 262-798-1910 | |
Annette Quinn, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Prohealth Care Women's Center, Waukesha, WI 53188 Phone: 262-928-3500 | |
Renelle L Staus, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W231n1440 Corporate Ct, Waukesha, WI 53186 Phone: 262-896-6000 | |
Ms. Danielle Marie Bernacchi, MSN, FNP-C, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W308s2809 Wild Berry Ct, Waukesha, WI 53188 Phone: 262-391-0575 | |
Katie L Scott, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave Ste 310, Waukesha, WI 53188 Phone: 262-928-5900 | |
Kaitlyn Solveson, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2428 N Grandview Blvd Ste 102, Waukesha, WI 53188 Phone: 877-307-3226 Fax: 866-384-9486 |